205 related articles for article (PubMed ID: 18089787)
1. Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer.
Strati K; Lambert PF
Cancer Res; 2007 Dec; 67(24):11585-93. PubMed ID: 18089787
[TBL] [Abstract][Full Text] [Related]
2. Pocket proteins suppress head and neck cancer.
Shin MK; Pitot HC; Lambert PF
Cancer Res; 2012 Mar; 72(5):1280-9. PubMed ID: 22237625
[TBL] [Abstract][Full Text] [Related]
3. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
4. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
[TBL] [Abstract][Full Text] [Related]
5. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.
Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E
Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625
[TBL] [Abstract][Full Text] [Related]
7. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
8. Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.
Balsitis SJ; Sage J; Duensing S; Münger K; Jacks T; Lambert PF
Mol Cell Biol; 2003 Dec; 23(24):9094-103. PubMed ID: 14645521
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma.
Zumbach K; Hoffmann M; Kahn T; Bosch F; Gottschlich S; Görögh T; Rudert H; Pawlita M
Int J Cancer; 2000 Mar; 85(6):815-8. PubMed ID: 10709102
[TBL] [Abstract][Full Text] [Related]
11. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
[TBL] [Abstract][Full Text] [Related]
13. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.
Smeets SJ; van der Plas M; Schaaij-Visser TB; van Veen EA; van Meerloo J; Braakhuis BJ; Steenbergen RD; Brakenhoff RH
Int J Cancer; 2011 Apr; 128(7):1596-605. PubMed ID: 20499310
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
Song S; Gulliver GA; Lambert PF
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
[TBL] [Abstract][Full Text] [Related]
15. Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
Qin T; Koneva LA; Liu Y; Zhang Y; Arthur AE; Zarins KR; Carey TE; Chepeha D; Wolf GT; Rozek LS; Sartor MA
Head Neck; 2020 Sep; 42(9):2375-2389. PubMed ID: 32406560
[TBL] [Abstract][Full Text] [Related]
16. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M
Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
[TBL] [Abstract][Full Text] [Related]
18. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.
Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW
Carcinogenesis; 2015 Nov; 36(11):1397-406. PubMed ID: 26354779
[TBL] [Abstract][Full Text] [Related]
19. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
[TBL] [Abstract][Full Text] [Related]
20. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
